An Examination of Glaxosmithkline Performance in Society
Companies are expected by society to act responsibly which translates into a set of corporate responsibility principles, the outcome being a substantial difference to the durability, prosperity and liveability of the communities in which they operate (Smith 2008).GlaxoSmithKline is a world leading research based pharmaceutical company, with a mission that is challenging and arousing to improve the quality of human life. GlaxoSmithKline has a robust combination of resources and skills delivering strong growth in today’s rapidly changing environment (Pangarkar 2006). The company also has leadership in four major therapeutic areas, anti infective, central nervous system, respiratory and gastro intestinal/metabolic and is also leading in the important area of vaccines (Tregear 2005). Therefore, this essay evaluates GlaxoSmithKline’s social performance in relation to the environment. It focuses on their corporate responsibility and portrays both positives and negatives in their operations and their impact on the environment and its stakeholders.
GlaxoSmithKline achievements and social performance
Companies are growingly discussing Corporate Social Responsibility at their highest level. Strong practices result in to a solid company reputation (Othman and Ameer 2009). In a New York news publication GlaxoSmithKline report confirms progress and dedication to its extensive approach in meeting society’s needs. Areas such as access to medication in developing countries and research and development in such nations, training of employees, environmental responsibility and conservation of environment, flora and fauna are widely supported by GlaxoSmithKline (GSK confirms Global Commitment to Corporate and Social Responsibility 2003).
The company’s achievements in Research and development are significant, contribution to society by discovering new ways of treating and preventing diseases. An investment of 500 million pounds has been made for product innovations. In addition the
GlaxoSmithKline achievements and social performance
Companies are growingly discussing Corporate Social Responsibility at their highest level. Strong practices result in to a solid company reputation (Othman and Ameer 2009). In a New York news publication GlaxoSmithKline report confirms progress and dedication to its extensive approach in meeting society’s needs. Areas such as access to medication in developing countries and research and development in such nations, training of employees, environmental responsibility and conservation of environment, flora and fauna are widely supported by GlaxoSmithKline (GSK confirms Global Commitment to Corporate and Social Responsibility 2003).
The company’s achievements in Research and development are significant, contribution to society by discovering new ways of treating and preventing diseases. An investment of 500 million pounds has been made for product innovations. In addition the